GlaxoSmithKline (China)

300 papers and 9.1k indexed citations i.

About

In recent decades, authors affiliated with GlaxoSmithKline (China) have published 300 papers, which have received a total of 9.1k indexed citations. Scholars at this organization have produced 67 papers in Molecular Biology, 57 papers in Physiology and 52 papers in Cellular and Molecular Neuroscience on the topics of Neuroscience and Neuropharmacology Research (27 papers), Asthma and respiratory diseases (25 papers) and Alzheimer's disease research and treatments (21 papers). Their work is cited by papers focused on Molecular Biology (2.5k citations), Physiology (1.8k citations) and Cellular and Molecular Neuroscience (1.8k citations). Authors at GlaxoSmithKline (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of GlaxoSmithKline (China)'s most productive authors include Bai Lu, Guhan Nagappan, Pradeep J. Nathan, Paul Wren, Xiao-Ming Guan, Jingwu Z. Zhang, Yuanyuan Ji, Taylor B. Guo, David J. Delgado and Gary H. Lyman.

In The Last Decade

Fields of papers published by authors at GlaxoSmithKline (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GlaxoSmithKline (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GlaxoSmithKline (China) at the time of their publication.

Countries citing scholars working at GlaxoSmithKline (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GlaxoSmithKline (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GlaxoSmithKline (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GlaxoSmithKline (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025